Metabolic biomarkers differentiate extrapulmonary tuberculosis from pulmonary TB and non-TB pleural effusions - Scorecard - MDSpire

Metabolic biomarkers differentiate extrapulmonary tuberculosis from pulmonary TB and non-TB pleural effusions

  • By

  • Holly May-Lewis

  • Michael James Perret

  • Ye Xu

  • Roberto Stefan Almeida Ribeiro

  • Raquel da Silva Correa

  • Thiago Thomaz Mafort

  • Ana Paula Santos

  • Rogério Rufino

  • Luciana Rodrigues

  • Khushboo Borah Slater

  • June 11, 2026

  • 0 min

Share

Clinical Scorecard: Metabolic Biomarkers Distinguish Extrapulmonary Tuberculosis from Pulmonary TB and Non-Tuberculous Pleural Effusions

At a Glance

CategoryDetail
ConditionPleural TB (PlTB)
Key Mechanisms
Target Population
Care Setting

Key Highlights

  • Add highlight on limitations of current diagnostic methods.

Guideline-Based Recommendations

Diagnosis

  • Include specific diagnostic methods currently used for PlTB.

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clarify how novel biomarkers enhance treatment management.

        Clinical Best Practices

        • Suggest incorporating existing diagnostic methods alongside new biomarkers.

        Related Resources & Content

        Original Source(s)

        Metabolic biomarkers differentiate extrapulmonary tuberculosis from pulmonary TB and non-TB pleural effusions

        • by Holly May-Lewis, Michael James Perret, Ye Xu, Roberto Stefan Almeida Ribeiro, Raquel da Silva Correa, Thiago Thomaz Mafort, Ana Paula Santos, Rogério Rufino, Luciana Rodrigues, Khushboo Borah Slater

        • June 11, 2026

        Related Content

        House Appropriations Committee Releases FY 2027 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) Appropriations Bill & Accompanying Report

        Weekly HIV Regimen Meets Phase 3 Goal

        The investigational combination pairs islatravir and lenacapavir in a once-weekly single-tablet regimen.

        Medical Oddities: The Economics of Shut-Eye

        Sleep became a commodity, tea became a therapy, and cats got a reprieve this week.